PMCF Adequacy Review & Post-Market Clinical Follow-Up Planning
Strengthen your PMCF strategy with expert review and planning support designed for EU MDR expectations. Elexes helps medical device manufacturers assess PMCF adequacy, identify evidence gaps, refine methods, and build defensible follow-up plans that align with clinical evaluation, post-market surveillance, and Notified Body scrutiny.
Our PMCF Adequacy Review & Post-Market Clinical Follow-Up Planning Services
Targeted PMCF support for review, planning, remediation, and evidence alignment under EU MDR.
PMCF Review
Structured assessment of your existing PMCF plan and evaluation reports to determine whether methods, rationale, and outputs are sufficient for EU MDR and Notified Body expectations.
PMCF Planning
Development of proportionate PMCF plans that define objectives, methods, data sources, timelines, and deliverables aligned with device risk, clinical claims, and post-market obligations.
Clinical Evidence Strategy
Integration of PMCF activities with CER updates, PMS outputs, literature, registries, and real-world evidence to create a coherent and defensible clinical evidence framework.
Gap Remediation
Identification of PMCF weaknesses with clear remediation actions covering study design, survey structure, data collection methods, and report completeness for regulatory readiness.
PMS Alignment
Alignment of PMCF planning with broader post-market surveillance processes so complaint trends, vigilance data, and field feedback support ongoing clinical evaluation.
EU MDR Support
Hands-on consulting for PMCF programs built to MDCG guidance and EU MDR expectations, helping manufacturers prepare for review by Notified Bodies with confidence.
EU MDR Ready
Build a Defensible PMCF Program
PMCF is not just a document requirement; it is a critical part of demonstrating ongoing safety, performance, and clinical benefit. Elexes helps manufacturers evaluate whether current PMCF activities are proportionate, methodologically sound, and properly connected to CER, PMS, and risk management outputs. The result is a clearer regulatory position, stronger documentation, and a more credible post-market clinical strategy.
Trusted By Manufacturers
Success Stories
See how manufacturers strengthen PMCF documentation and post-market clinical strategy with expert regulatory support.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for practical, evidence-based regulatory support across the full device lifecycle.
Deep Expertise
50+ years of collective experience across clinical, regulatory, and quality requirements for medical devices.
End-to-End Support
From evidence gaps to PMCF planning, Elexes supports review, remediation, and lifecycle integration.
Global Perspective
Experienced across EU MDR, FDA, Health Canada, TGA, and other major regulatory frameworks.
Proven Results
250+ successful projects and a 90% audit clearance rate demonstrate disciplined execution.
Meet The Elexes Team
Experienced consultants supporting complex regulatory and clinical needs.
Elexes Medical Consulting Pvt. Ltd. has built its reputation by helping medical device manufacturers navigate complex regulatory and quality requirements with confidence. Over the years, Elexes has become a trusted consulting partner for companies seeking support across regulatory approvals, clinical documentation, QMS systems, and post-market obligations. The team brings deep cross-functional expertise spanning regulatory affairs, clinical evidence, risk management, and quality systems, allowing clients to solve interconnected compliance challenges rather than isolated tasks. With experience supporting more than 200 global clients across 200+ product types and 250+ successful projects, Elexes focuses on practical, defensible solutions that reduce delays, strengthen submissions, and support long-term market continuity.
50+ YearsCollective regulatory and compliance experience250+ ProjectsSuccessful engagements delivered across device categories200+ Product TypesSupported with tailored regulatory strategies
Frequently Asked Questions
What is a PMCF plan?
A PMCF plan is a structured post-market clinical follow-up document that explains how a manufacturer will collect and evaluate clinical data after a device is on the market. Under EU MDR, it typically defines the PMCF objectives, rationale, methods, data sources, timelines, and responsibilities. The plan should show how ongoing clinical evidence will confirm safety, performance, and benefit-risk acceptability throughout the device lifecycle.
What is the PMCF method?
The PMCF method refers to the specific approach used to gather post-market clinical data for a medical device. Common methods include literature reviews, user surveys, registry analysis, post-market clinical investigations, and analysis of complaint or field data. The right method depends on the device’s risk profile, novelty, clinical claims, residual risks, and the strength of existing evidence supporting ongoing safety and performance.
When is a PMCF adequacy review needed?
A PMCF adequacy review is especially valuable before Notified Body submission, during CER updates, after significant device changes, or when existing PMCF documentation feels weak or outdated. It helps determine whether your current plan and reports are proportionate, scientifically justified, and aligned with EU MDR and MDCG expectations. Early review can prevent deficiencies, repeated questions, and costly remediation later in the process.
What does a PMCF adequacy review include?
A thorough PMCF adequacy review examines the rationale for PMCF, selected methods, study design quality, data sources, endpoints, timelines, and report completeness. It also checks whether PMCF outputs are properly linked to the CER, PMS system, risk management file, and benefit-risk conclusions. The goal is to identify gaps clearly and provide a prioritized path to make the PMCF program more defensible and submission-ready.
How do you decide which PMCF activities are appropriate?
Appropriate PMCF activities are selected based on the device’s classification, novelty, intended purpose, residual risks, clinical claims, and the maturity of existing clinical evidence. For some devices, literature and complaint trending may be sufficient when well justified. For others, surveys, registries, or formal clinical investigations may be necessary. The decision should be documented with a clear rationale showing proportionality and regulatory defensibility.
Can PMCF be waived under EU MDR?
In limited cases, manufacturers may justify why extensive PMCF activities are not necessary, but this requires strong evidence and a well-documented rationale. A simple statement that PMCF is unnecessary is usually not enough. The justification must show that existing clinical evidence, PMS data, and risk management outputs are sufficient to confirm ongoing safety and performance without additional follow-up activities.
How does PMCF connect to the CER and PMS?
PMCF is a core input to both the Clinical Evaluation Report and the broader post-market surveillance system. PMCF findings help confirm whether clinical claims remain valid, whether new risks are emerging, and whether benefit-risk conclusions still hold. Those outputs should feed into CER updates, PMS reports, PSURs where applicable, and risk management reviews so the manufacturer maintains a consistent and current evidence base.
What are common PMCF deficiencies seen by reviewers?
Common deficiencies include vague PMCF objectives, weak justification for chosen methods, missing links to residual risks, poorly designed surveys or studies, and reports that summarize data without meaningful analysis. Reviewers also flag PMCF plans that are disconnected from CER conclusions or PMS processes. Strong PMCF documentation should be specific, proportionate, traceable, and clearly tied to ongoing clinical evidence needs.
Still Have Questions About PMCF?
Speak with our regulatory experts about your PMCF strategy.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise
MDSAP
Multi-market audit readiness support
IEC 62304
Software lifecycle compliance knowledge
